Further studies conducted in dogs with mammary tumors, which addressed the evaluation of mechanisms that regulate the efficacy of p62 DNA against cancer, indicate that the administration of a plasmid provokes a rearrangement in the tumor microenvironment decreasing both the size and the aggressivity of the tumor. The gene discussed is SQSTM1; the disease is cancer.